Skip to content

Clinical trials

Phase 2/3 Hypoxia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoxia Phase: Phase 2/3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20152
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ansun Biopharma, Inc.1
Copenhagen University Hospital, Hvidovre1
Great Ormond Street Hospital for Children NHS Foundation Trust1
Istanbul University1
Max-Planck-Institute of Experimental Medicine1
University Hospital, Clermont-Ferrand1
University of Utah1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoxia7
Acidosis, Respiratory1
COVID-191
Coronavirus Infections1
Dyspnea1
Heart Defects, Congenital1
Infarction, Middle Cerebral Artery1
Ischemia1
Lymphoma, Follicular1
Neurodevelopmental Disorders1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.